Umbilical cord blood is a valuable source of stem cells that can be used in the treatment of a variety of conditions, such as leukemia and other blood disorders. These stem cells, collected at birth from the umbilical cord, offer potential treatment options for the child and, in some cases, for compatible family members.
We have always set the highest standards in our field by focusing on scientific innovation, quality customer service and absolute transparency. This allows us to offer a leading stem cell biobank in Switzerland, offering more personalized and humane solutions.
Umbilical Cord Blood
Preserve hematopoietic stem cells from your baby's cord blood, which are capable of producing all the cells of the blood and immune system. They have been used to treat over 80 diseases and are used in many clinical trials.
Preserve cord tissue, which is a source of mesenchymal stem cells (MSCs) that can regenerate bone, cartilage, and muscle. Used in regenerative medicine, they are being studied in over 1,000 clinical trials to treat diseases such as cerebral palsy, arthritis, and type 1 diabetes.
Preserving placental stem cells, which are promising in regenerative medicine and used to treat diseases such as multiple sclerosis and neurological disorders. Their use is growing, with more than 23,000 clinical trials and 40 approved therapies.
Our biobank enjoys international recognition and is considered one of the safest and most highly rated centers for cryopreservation and biological storage in the world. In fact, we regularly collaborate with several countries, including:
Germany
India
Portugal
Spain
Italy
Romania
United States
Monaco
Ukraine
France
Pakistan
Bahrain
Our partners
Adresse
CORDSAVINGS SA Route de l’Ile-au-Bois 1A 1870 Monthey (Switzerland)